149 related articles for article (PubMed ID: 34133781)
1. First-line pharmacotherapy for incident type 2 diabetes: Prescription patterns, adherence and associated costs.
Campbell DJT; Campbell DB; Ogundeji Y; Au F; Beall R; Ronksley PE; Quinn AE; Manns BJ; Hemmelgarn BR; Tonelli M; Spackman E
Diabet Med; 2021 Sep; 38(9):e14622. PubMed ID: 34133781
[TBL] [Abstract][Full Text] [Related]
2. Patterns of metformin use and glycated haemoglobin trends among patients with newly diagnosed type 2 diabetes in Alberta, Canada.
Kim T; Campbell DB; Au F; Ronksley PE; Weaver RG; Campbell DJT
Diabetes Obes Metab; 2024 Apr; 26(4):1234-1243. PubMed ID: 38164697
[TBL] [Abstract][Full Text] [Related]
3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
4. Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study.
Buysman EK; Liu F; Hammer M; Langer J
Adv Ther; 2015 Apr; 32(4):341-55. PubMed ID: 25832470
[TBL] [Abstract][Full Text] [Related]
5. Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis.
Balkrishnan R; Rajagopalan R; Shenolikar RA; Camacho FT; Whitmire JT; Anderson RT
Curr Med Res Opin; 2004 Oct; 20(10):1633-40. PubMed ID: 15462696
[TBL] [Abstract][Full Text] [Related]
6. Depression and antecedent medication adherence in a cohort of new metformin users.
Niaz D; Necyk C; Simpson SH
Diabet Med; 2021 Feb; 38(2):e14426. PubMed ID: 33064895
[TBL] [Abstract][Full Text] [Related]
7. A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005.
Hansen RA; Farley JF; Droege M; Maciejewski ML
Clin Ther; 2010 Jul; 32(7):1308-19. PubMed ID: 20678679
[TBL] [Abstract][Full Text] [Related]
8. Real-world treatment escalation from metformin monotherapy in youth-onset Type 2 diabetes mellitus: A retrospective cohort study.
Vajravelu ME; Hitt TA; Amaral S; Levitt Katz LE; Lee JM; Kelly A
Pediatr Diabetes; 2021 Sep; 22(6):861-871. PubMed ID: 33978986
[TBL] [Abstract][Full Text] [Related]
9. Patterns and determinants of new first-line antihyperglycaemic drug use in patients with type 2 diabetes mellitus.
Geier AS; Wellmann I; Wellmann J; Kajüter H; Heidinger O; Hempel G; Hense HW
Diabetes Res Clin Pract; 2014 Oct; 106(1):73-80. PubMed ID: 25139631
[TBL] [Abstract][Full Text] [Related]
10. Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications.
Liao EP
Am J Med; 2012 Oct; 125(10):S1-2. PubMed ID: 22998891
[TBL] [Abstract][Full Text] [Related]
11. Metformin adherence in patients with type 2 diabetes and its association with glycated haemoglobin levels.
Chepulis L; Mayo C; Morison B; Keenan R; Lao C; Paul R; Lawrenson R
J Prim Health Care; 2020 Dec; 12(4):318-326. PubMed ID: 33349319
[TBL] [Abstract][Full Text] [Related]
12. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
13. Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US.
Perez-Nieves M; Kabul S; Desai U; Ivanova JI; Kirson NY; Cummings AK; Birnbaum HG; Duan R; Cao D; Hadjiyianni I
Curr Med Res Opin; 2016; 32(4):669-80. PubMed ID: 26703951
[TBL] [Abstract][Full Text] [Related]
14. Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study.
Hazel-Fernandez L; Louder AM; Foster SA; Uribe CL; Burge RT
BMC Musculoskelet Disord; 2013 Jan; 14():4. PubMed ID: 23281846
[TBL] [Abstract][Full Text] [Related]
15. Effects of early medication treatment and metformin use for cancer prevention in diabetes patients: a nationwide sample cohort study in Korea using extended landmark time analysis.
Seo HJ; Oh HS
Epidemiol Health; 2021; 43():e2021103. PubMed ID: 34922421
[TBL] [Abstract][Full Text] [Related]
16. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
[TBL] [Abstract][Full Text] [Related]
17. Initial treatment of diabetes in Italy. A nationwide population-based study from of the ARNO Diabetes Observatory.
Bonora E; Cataudella S; Marchesini G; Miccoli R; Vaccaro O; Fadini GP; Martini N; Rossi E;
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2661-2668. PubMed ID: 34218990
[TBL] [Abstract][Full Text] [Related]
18. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy.
Barner JC
Clin Ther; 2011 Sep; 33(9):1281-8. PubMed ID: 21840054
[TBL] [Abstract][Full Text] [Related]
19. Predictors of non-adherence to pharmacotherapy in patients with type 2 diabetes.
Jarab AS; Almrayat R; Alqudah S; Thehairat E; Mukattash TL; Khdour M; Pinto S
Int J Clin Pharm; 2014 Aug; 36(4):725-33. PubMed ID: 24805800
[TBL] [Abstract][Full Text] [Related]
20. [Characterization of and costs associated to the profile of patients with type 2 diabetes treated with metformin who are added a second oral antidiabetic drug: a population study].
Sicras-Mainar A; Font-Ramos B; Roldán-Suárez C; Navarro-Artieda R; Ibáñez-Nolla J
Endocrinol Nutr; 2013 Dec; 60(10):557-69. PubMed ID: 24008167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
